Syndromic Multiplex Diagnostic Market 2027 | The Insight Partners

Syndromic Multiplex Diagnostic Market to 2027 - Global Analysis and Forecasts By Syndromes (Gastrointestinal, Central Nervous System, Bloodstream, Pneumonia, Respiratory); End User (Hospitals, Diagnostics Laboratories, Research Institutes, Others)

Report Code: TIPRE00007425 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION

Syndromic testing is proving itself in the market. Players are reporting double-digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. A syndrome is a set of medical signs and symptoms and collection of diseases which are not correlated with each other and often associated with a particular disease or disorder.

MARKET DYNAMICS

The syndromic multiplex diagnostic market is anticipated to grow in the market by the advancement of new technologies. In addition, improvement in the outcomes result in the rising market growth. It has increased demand for minimally invasive surgeries that has the opportunity for market growth.

MARKET SCOPE

The "Syndromic Multiplex Diagnostic Market Analysis to 2027" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of in syndromic multiplex diagnostic market with detailed market segmentation by syndromes, end user and geography. The syndromic multiplex diagnostic market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in syndromic multiplex diagnostic market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The syndromic multiplex diagnostic market is segmented on the basis of syndromes and by end user. Based on syndromes the market is segmented as gastrointestinal, central nervous system, bloodstream, pneumonia and respiratory. On the basis of end user the market is categorized as hospitals, diagnostics laboratories, research institutes and others.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in syndromic multiplex diagnostic market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The syndromic multiplex diagnostic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting syndromic multiplex diagnostic market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the syndromic multiplex diagnostic market in these regions.

MARKET PLAYERS


The report covers key developments in the in syndromic multiplex diagnostic market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in syndromic multiplex diagnostic market are anticipated to have lucrative growth opportunities in the future with the rising demand for in syndromic multiplex diagnostic market in the global market. Below mentioned is the list of few companies engaged in the Syndromic Multiplex Diagnostic market.

The report also includes the profiles of key in syndromic multiplex diagnostic market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott Laboratories
  •  Akonni Biosystems, Inc.
  •  Applied BioCode, Inc
  •  BioFire Diagnostics
  •  GenePOC Inc
  •  GenMark Diagnostics
  •  Janssen Global Services, LLC,(Johnson & Johnson)
  •  Luminex Corporation
  •  Mesa Biotech
  •  Qiagen

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Syndromic Multiplex Diagnostic Market - By Syndromes
1.3.2 Syndromic Multiplex Diagnostic Market - By End User
1.3.3 Syndromic Multiplex Diagnostic Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. SYNDROMIC MULTIPLEX DIAGNOSTIC - GLOBAL MARKET OVERVIEW
6.2. SYNDROMIC MULTIPLEX DIAGNOSTIC - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2027 - SYNDROMES
7.1. OVERVIEW
7.2. SYNDROMES MARKET FORECASTS AND ANALYSIS
7.3. GASTROINTESTINAL
7.3.1. Overview
7.3.2. Gastrointestinal Market Forecast and Analysis
7.4. CENTRAL NERVOUS SYSTEM
7.4.1. Overview
7.4.2. Central Nervous System Market Forecast and Analysis
7.5. BLOODSTREAM
7.5.1. Overview
7.5.2. Bloodstream Market Forecast and Analysis
7.6. PNEUMONIA
7.6.1. Overview
7.6.2. Pneumonia Market Forecast and Analysis
7.7. RESPIRATORY
7.7.1. Overview
7.7.2. Respiratory Market Forecast and Analysis
8. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. DIAGNOSTICS LABORATORIES
8.4.1. Overview
8.4.2. Diagnostics Laboratories Market Forecast and Analysis
8.5. RESEARCH INSTITUTES
8.5.1. Overview
8.5.2. Research Institutes Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Syndromic Multiplex Diagnostic Market Overview
9.1.2 North America Syndromic Multiplex Diagnostic Market Forecasts and Analysis
9.1.3 North America Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Syndromes
9.1.4 North America Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By End User
9.1.5 North America Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Countries
9.1.5.1 United States Syndromic Multiplex Diagnostic Market
9.1.5.1.1 United States Syndromic Multiplex Diagnostic Market by Syndromes
9.1.5.1.2 United States Syndromic Multiplex Diagnostic Market by End User
9.1.5.2 Canada Syndromic Multiplex Diagnostic Market
9.1.5.2.1 Canada Syndromic Multiplex Diagnostic Market by Syndromes
9.1.5.2.2 Canada Syndromic Multiplex Diagnostic Market by End User
9.1.5.3 Mexico Syndromic Multiplex Diagnostic Market
9.1.5.3.1 Mexico Syndromic Multiplex Diagnostic Market by Syndromes
9.1.5.3.2 Mexico Syndromic Multiplex Diagnostic Market by End User
9.2. EUROPE
9.2.1 Europe Syndromic Multiplex Diagnostic Market Overview
9.2.2 Europe Syndromic Multiplex Diagnostic Market Forecasts and Analysis
9.2.3 Europe Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Syndromes
9.2.4 Europe Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By End User
9.2.5 Europe Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Syndromic Multiplex Diagnostic Market
9.2.5.1.1 Germany Syndromic Multiplex Diagnostic Market by Syndromes
9.2.5.1.2 Germany Syndromic Multiplex Diagnostic Market by End User
9.2.5.2 France Syndromic Multiplex Diagnostic Market
9.2.5.2.1 France Syndromic Multiplex Diagnostic Market by Syndromes
9.2.5.2.2 France Syndromic Multiplex Diagnostic Market by End User
9.2.5.3 Italy Syndromic Multiplex Diagnostic Market
9.2.5.3.1 Italy Syndromic Multiplex Diagnostic Market by Syndromes
9.2.5.3.2 Italy Syndromic Multiplex Diagnostic Market by End User
9.2.5.4 Spain Syndromic Multiplex Diagnostic Market
9.2.5.4.1 Spain Syndromic Multiplex Diagnostic Market by Syndromes
9.2.5.4.2 Spain Syndromic Multiplex Diagnostic Market by End User
9.2.5.5 United Kingdom Syndromic Multiplex Diagnostic Market
9.2.5.5.1 United Kingdom Syndromic Multiplex Diagnostic Market by Syndromes
9.2.5.5.2 United Kingdom Syndromic Multiplex Diagnostic Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Overview
9.3.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Forecasts and Analysis
9.3.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Syndromes
9.3.4 Asia-Pacific Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Syndromic Multiplex Diagnostic Market
9.3.5.1.1 Australia Syndromic Multiplex Diagnostic Market by Syndromes
9.3.5.1.2 Australia Syndromic Multiplex Diagnostic Market by End User
9.3.5.2 China Syndromic Multiplex Diagnostic Market
9.3.5.2.1 China Syndromic Multiplex Diagnostic Market by Syndromes
9.3.5.2.2 China Syndromic Multiplex Diagnostic Market by End User
9.3.5.3 India Syndromic Multiplex Diagnostic Market
9.3.5.3.1 India Syndromic Multiplex Diagnostic Market by Syndromes
9.3.5.3.2 India Syndromic Multiplex Diagnostic Market by End User
9.3.5.4 Japan Syndromic Multiplex Diagnostic Market
9.3.5.4.1 Japan Syndromic Multiplex Diagnostic Market by Syndromes
9.3.5.4.2 Japan Syndromic Multiplex Diagnostic Market by End User
9.3.5.5 South Korea Syndromic Multiplex Diagnostic Market
9.3.5.5.1 South Korea Syndromic Multiplex Diagnostic Market by Syndromes
9.3.5.5.2 South Korea Syndromic Multiplex Diagnostic Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Syndromic Multiplex Diagnostic Market Overview
9.4.2 Middle East and Africa Syndromic Multiplex Diagnostic Market Forecasts and Analysis
9.4.3 Middle East and Africa Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Syndromes
9.4.4 Middle East and Africa Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Syndromic Multiplex Diagnostic Market
9.4.5.1.1 South Africa Syndromic Multiplex Diagnostic Market by Syndromes
9.4.5.1.2 South Africa Syndromic Multiplex Diagnostic Market by End User
9.4.5.2 Saudi Arabia Syndromic Multiplex Diagnostic Market
9.4.5.2.1 Saudi Arabia Syndromic Multiplex Diagnostic Market by Syndromes
9.4.5.2.2 Saudi Arabia Syndromic Multiplex Diagnostic Market by End User
9.4.5.3 U.A.E Syndromic Multiplex Diagnostic Market
9.4.5.3.1 U.A.E Syndromic Multiplex Diagnostic Market by Syndromes
9.4.5.3.2 U.A.E Syndromic Multiplex Diagnostic Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Syndromic Multiplex Diagnostic Market Overview
9.5.2 South and Central America Syndromic Multiplex Diagnostic Market Forecasts and Analysis
9.5.3 South and Central America Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Syndromes
9.5.4 South and Central America Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By End User
9.5.5 South and Central America Syndromic Multiplex Diagnostic Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Syndromic Multiplex Diagnostic Market
9.5.5.1.1 Brazil Syndromic Multiplex Diagnostic Market by Syndromes
9.5.5.1.2 Brazil Syndromic Multiplex Diagnostic Market by End User
9.5.5.2 Argentina Syndromic Multiplex Diagnostic Market
9.5.5.2.1 Argentina Syndromic Multiplex Diagnostic Market by Syndromes
9.5.5.2.2 Argentina Syndromic Multiplex Diagnostic Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AKONNI BIOSYSTEMS, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. APPLIED BIOCODE, INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIOFIRE DIAGNOSTICS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GENEPOC INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GENMARK DIAGNOSTICS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JANSSEN GLOBAL SERVICES, LLC,(JOHNSON AND JOHNSON)
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. LUMINEX CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MESA BIOTECH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. QIAGEN
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Akonni Biosystems, Inc.
3. Applied BioCode, Inc
4. BioFire Diagnostics
5. GenePOC Inc
6. GenMark Diagnostics
7. Janssen Global Services, LLC,(Johnson & Johnson)
8. Luminex Corporation
9. Mesa Biotech
10. Qiagen